Venclyxto 100 mg, 28 tablets (Venetoclax 100 mg per tablet) by AbbVie.
Indications: Chronic lymphocytic leukaemia and acute myeloid leukaemia (with hypomethylating agent).
Administration: Oral, once daily with a meal after a 5-week dose ramp-up (CLL); tumour lysis prophylaxis required.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | AbbVie |
| Active ingredient | Venetoclax 100 mg per tablet — BCL-2 inhibitor. |
| Strength & pack | 28 film-coated tablets. |
| Form | Film-coated tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |